scispace - formally typeset
F

Fei Li

Researcher at Xi'an Jiaotong University

Publications -  1067
Citations -  23099

Fei Li is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 57, co-authored 482 publications receiving 15237 citations. Previous affiliations of Fei Li include Nanjing Agricultural University & Laboratory of Molecular Biology.

Papers
More filters
Posted ContentDOI

Characterization of N distribution in different organs of winter wheat using UAV-based remote sensing

Falv Wang, +9 more
- 03 Nov 2022 - 
TL;DR: In this paper , the performance of UAV-based image texture features in crop nitrogen and NUE monitoring was evaluated using eight flying missions to acquire multispectral images of winter wheat.
Patent

Polarization method for obtaining single-domain relaxor-based ferroelectric crystal

Fei Li, +3 more
TL;DR: In this paper, a polarization method for obtaining single-domain relaxor-based ferroelectric crystal was proposed, aiming at tetragonal-phase, trilateral-phase and quadrature-phase.
Journal ArticleDOI

Efficacy of Low Molecular Weight Heparin in Preventing Perinatal Venous Thrombosis: A Meta-Analysis

Yan Huang, +3 more
- 26 Jul 2022 - 
TL;DR: LMWH can reduce the incidence of perinatal VT in high-risk women but increase the risk of bleeding, and the use of LMWH to prevent per inatal VT should be closely monitored.
Proceedings ArticleDOI

Simulation of Insulation Electric Field of HVDC XLPE Cable Based on Radial Non-uniform Conductivity Distribution

Muneeb Ahmed, +4 more
TL;DR: In this article, the radially distributed non-uniform conductivity in XLPE insulation of a degassed 500 kV DC cables is examined at different field stresses and temperatures.
Journal ArticleDOI

Preliminary Safety and Efficacy Evaluation of IMM0306, a CD47 and CD20 Bispecific Monoclonal Antibody-Trap (mAb-Trap), from an Ongoing Phase I Dose-Escalation Study in Patients with Relapsed or Refractory B-Cell Non- Hodgkin's Lymphoma (R/R B-NHL)

Yuankai Shi, +14 more
- 15 Nov 2022 - 
TL;DR: In this paper , the authors present preliminary safety and efficacy data from an ongoing dose-escalation study in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (R/R B-NHL).